A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

Last updated:
2026-08-01
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A MULTINATIONAL, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFECT OF TICAGRELOR 90 MG TWICE DAILY ON THE INCIDENCE OF CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION OR STROKE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Intervention/treatment:
BRILINTA (TICAGRELOR, AZD6140)
Medical condition:
TYPE 2 DIABETES
Protocol code:
D513BC00001
Control number:
170633
Status:
Closed
Approved:
January 06, 2014
Date Completed:
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT01991795
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
50 Years to 130 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Global Clinical Lead
Organization
Study Information Center
Phone:
+1-877-240-9479
Sponsor
ASTRAZENECA CANADA INC

Locations

Alberta

Research Site
Calgary, Alberta, T2V 4J2
Research Site
Edmonton, Alberta, T5A 4L8
Research Site
Edmonton, Alberta, T5H 3V9
Research Site
Edmonton, Alberta, T6G 2E1
Research Site
Red Deer, Alberta, T4N 6V7
Research Site
Spruce Grove, Alberta, T7X 2V2
Research Site
Chicoutimi, Alberta, G7H 5H6

British Columbia

Research Site
Kelowna, British Columbia, V1Y 1V6
Research Site
New Westminster, British Columbia, V3L 3W4
Research Site
Penticton, British Columbia, V2A 5C8
Research Site
Surrey, British Columbia, V3V 0C6
Research Site
Vancouver, British Columbia, V5Z 1M9
Research Site
Victoria, British Columbia, V8R 4R2

New Brunswick

Research Site
Saint John, New Brunswick, E2L 4L2

Newfoundland and Labrador

Research Site
Mount Pearl, Newfoundland and Labrador, A1N 1W7
Research Site
St. John's, Newfoundland and Labrador, A1A 3R5
Research Site
St. John's, Newfoundland and Labrador, A1B 3V6

Nova Scotia

Research Site
Halifax, Nova Scotia, B3H 3A7
Research Site
Halifax, Nova Scotia, B3S 1M7

Ontario

Research Site
Brampton, Ontario, L6W 2X7
Research Site
Cambridge, Ontario, N1R 6V6
Research Site
Cambridge, Ontario, N1R 7L6
Research Site
Cambridge, Ontario, N1R 7R1
Research Site
Cornwall, Ontario, K6H 4M4
Research Site
Greater Sudbury, Ontario, P3E 5M4
Research Site
Hamilton, Ontario, L8L 2X2
Research Site
Jarvis, Ontario, N0A 1J0
Research Site
London, Ontario, N6A 5A5
Research Site
London, Ontario, N6G 2M1
Research Site
Newmarket, Ontario, L3Y 2R2
Research Site
Newmarket, Ontario, L3Y 5G8
Research Site
North York, Ontario, M3M 3E5
Research Site
Oshawa, Ontario, L1J 2K1
Research Site
Ottawa, Ontario, K1Y 4W7
Research Site
Sarnia, Ontario, N7T 4X3
Research Site
Scarborough Village, Ontario, M1E 5E9
Research Site
Scarborough Village, Ontario, M1R 3A6
Research Site
Thornhill, Ontario, L4J 1W3
Research Site
Toronto, Ontario, M5B 1W8
Research Site
Toronto, Ontario, M5G 2C4
Research Site
Waterloo, Ontario, N2T 0C1

Quebec

Research Site
Brossard, Quebec, J4Z 2K9
Research Site
Chicoutimi, Quebec, G7H 7K9
Research Site
Greenfield Park, Quebec, J4V 2G8
Research Site
Laval, Quebec, H7M 3L9
Research Site
Laval, Quebec, H7T 2P5
Research Site
Longueuil, Quebec, J4M 2X1
Research Site
Montreal, Quebec, H1M 1B1
Research Site
Montreal, Quebec, H1T 1C8
Research Site
Montreal, Quebec, H1T 3Y7
Research Site
Montreal, Quebec, H2W 1T8
Research Site
Montreal, Quebec, H3G 1A4
Research Site
Québec, Quebec, G1G 3Y8
Research Site
Québec, Quebec, G1N 4V3
Research Site
Québec, Quebec, G1V 4G5
Research Site
Québec, Quebec, G1W 4R4
Research Site
Québec, Quebec, G2J 0C4
Research Site
Saint-Charles-Borromée, Quebec, J6E 6J2
Research Site
Saint-Georges, Quebec, G5Y 4T8
Research Site
Saint-Jean-sur-Richelieu, Quebec, J3A 1J2
Research Site
Saint-Lambert, Quebec, J4P 2H4
Research Site
Terrebonne, Quebec, J6V 2H2

Saskatchewan

Research Site
Regina, Saskatchewan, S4P 0W5

Results

See the results from the trial NCT01991795. This is an external link. The information is not authorized by the Government of Canada.

Date posted:
Did you find what you were looking for?